Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814433 · ClinicalTrials.gov registry record · Phase 4
Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
A Phase 4 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT04814433 is a Phase 4 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 46 participants.
The verdict
NCT04814433, a Phase 4 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study is a prospective randomized trial examining the effect of topically combined antifibrinolytics (Tranexamic acid) with local anesthetics in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics.
Interventions
- DRUG Tranexamic acid
- DRUG Aminocaproic acid
- DRUG Recombinant Human Thrombin
- DRUG Lidocaine Hydrochloride with Epinephrine
- DRUG Bupivacaine Hydrochloride with Epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2023-07-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04814433
The ClinicalTrials.gov registry entry for NCT04814433 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Tranexamic acid is the first listed.
NCT04814433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04814433 about?
NCT04814433 is a clinical study titled "Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation". This study is a prospective randomized trial examining the effect of topically combined antifibrinolytics (Tranexamic acid) with local anesthetics in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics.
What is the current status of trial NCT04814433?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2021-03-24. Estimated completion is 2023-07-10.
What interventions are being tested in trial NCT04814433?
The interventions under investigation include: Tranexamic acid (DRUG), Aminocaproic acid (DRUG), Recombinant Human Thrombin (DRUG), Lidocaine Hydrochloride with Epinephrine (DRUG), Bupivacaine Hydrochloride with Epinephrine (DRUG).
Who is sponsoring clinical trial NCT04814433?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.